Scientists test milder chemo for breast cancer, aim to reduce harsh side effects
NCT ID NCT07421141
Summary
This study is testing a new, potentially less toxic chemotherapy combination for people with early-stage HER2-positive breast cancer. Researchers want to see if this gentler treatment works as well as the standard, stronger chemotherapy at eliminating cancer before surgery. The study involves 186 participants and compares the new regimen to the standard treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
P.A. Hertsen Moscow Oncology Research Institute
Moscow, 125284, Russia
Conditions
Explore the condition pages connected to this study.